LexaGene: MiQLab System can detect monkeypox

By LabPulse.com staff writers

August 29, 2022 -- LexaGene announced on Monday that its MiQLab System can perform a real-time polymerase chain reaction (RT-PCR) test to detect monkeypox in accordance with the protocols of the Centers for Disease Control and Prevention (CDC).

"The MiQLab System is a platform that can be quickly configured to detect any new pathogen and for this reason we continue to advance it as a solution for rapidly detecting newly emergent pathogens at the point-of-care," Dr. Jack Regan, founder and CEO of LexaGene, said in a statement.

Monkeypox is a viral disease with no current cure. Symptoms in affected individuals include fever, swollen lymph nodes, and rashes. Such symptoms are particularly severe in children, pregnant women, and immunocompromised people.

As the number of monkeypox cases has grown worldwide, the World Health Organization (WHO) declared it to be a public health emergency on July 23. Following this, the U.S. declared the epidemic a public health emergency on August 4.

The CDC says that more than 17,000 cases have been confirmed in the U.S.

"The FDA has not yet declared an EUA for this epidemic, but should one be declared, LexaGene is in position to pursue such an authorization," Regan said.

According to LexaGene's website, the system is capable of testing for multiple pathogens onsite using RT-PCR chemistry and analysis. It has been used in biologics manufacturing, biothreat detection, human clinical diagnostics, and veterinary diagnostics.

The company emphasized that they make no claim at this time that its system can cure or eliminate monkeypox.

CorDx obtains CE Mark for monkeypox tests
CorDx has received the CE Mark for three diagnostic tests to detect the monkeypox virus.
GenScript launches monkeypox PCR test
GenScript USA has launched a real-time polymerase chain reaction (RT-PCR) monkeypox test for research lab use.
Qiagen launches syndromic monkeypox test for research
Qiagen has launched a research-use-only (RUO) syndromic test to differentiate between monkeypox and five other pathogens that cause similar symptoms.
LexaGene cease trade order no longer in effect
Molecular diagnostics company LexaGene announced on Friday that a management cease trade order issued by the British Columbia Securities Commission on...

Copyright © 2022 LabPulse.com

Last Updated mp 8/29/2022 10:36:28 AM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current